Skip to content

STRATOZE: what changed

What changed

STRATOZE

BE 0747.682.136
NACE 32.500, Manufacture of medical and dental instruments and supplies
filed annual accounts (NBB)
Financial years compared with
Net result for the year
-€24,909
2024 · -€171-€24,738
Equity
€53,213
2024 · €85,500-€32,287
Cash
€41,957
2024 · €42,880-€923
Balance sheet total
€54,781
2024 · €87,068-€32,287

Largest movements

2024 to 2025
Assets
  • Intangible fixed assets -€31,364

    down €31,364 (-71.0%), from €44,189 to €12,824

  • Cash -€923

    down €923 (-2.2%), from €42,880 to €41,957

    mainly Net result for the year (-€24,909) and Contributions, distributions and other (-€7,379)

Equity and liabilities
  • Profit (loss) carried forward -€24,909

    down €24,909 (-1,326%), from -€1,878 to -€26,787

  • Investment grants -€7,379

    no longer reported in 2025 (was €7,379)

Income statement
  • Financial income -€28,071

    down €28,071 (-79.2%), from €35,450 to €7,379

  • Depreciation -€4,086

    down €4,086 (-11.5%), from €35,450 to €31,364

  • Other operating charges +€811

    new in 2025: €811

  • Gross operating margin +€59

    up €59 (+47.1%), from -€124 to -€66

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€171
Gross operating margin +€59
Depreciation +€4,086
Other operating charges -€811
Financial income -€28,071
Result 2025 -€24,909
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€6,455
Investment €0
Financing -€7,379
Cash 2024 €42,880
Net result for the year -€24,909
Depreciation +€31,364
Contributions, distributions and other -€7,379
Cash 2025 €41,957
brings cash intakes cash out
Every line side by side 26 lines
Line Code 2024 2025 Change %
Total assets 20/58 €87,068 €54,781 -€32,287 -37.1%
Fixed assets 21/28 €44,189 €12,824 -€31,364 -71.0%
Intangible fixed assets 21 €44,189 €12,824 -€31,364 -71.0%
Current assets 29/58 €42,880 €41,957 -€923 -2.2%
Cash at bank and in hand 54/58 €42,880 €41,957 -€923 -2.2%
Total equity and liabilities 10/49 €87,068 €54,781 -€32,287 -37.1%
Equity 10/15 €85,500 €53,213 -€32,287 -37.8%
Contributions 10/11 €80,000 €80,000 = 0.0%
Contributions outside capital 11 €80,000 €80,000 = 0.0%
Other 1109/19 €80,000 €80,000 = 0.0%
Profit (loss) carried forward 14 -€1,878 -€26,787 -€24,909 -1,326%
Investment grants 15 €7,379 - -€7,379
Amounts payable 17/49 €1,568 €1,568 = 0.0%
Amounts payable within one year 42/48 €1,568 €1,568 = 0.0%
Other amounts payable 47/48 €1,568 €1,568 = 0.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €35,450 €31,364 -€4,086 -11.5%
Other operating charges 640/8 - €811 +€811
Gross operating margin 9900 -€124 -€66 +€59 +47.1%
Operating profit (loss) 9901 -€35,574 -€32,241 +€3,333 +9.4%
Financial income 75/76B €35,450 €7,379 -€28,071 -79.2%
Recurring financial income 75 €35,450 €7,379 -€28,071 -79.2%
Financial charges 65/66B €46 €46 = 0.0%
Recurring financial charges 65 €46 €46 = 0.0%
Profit (loss) for the period before taxes 9903 -€171 -€24,909 -€24,738 -14,506%
Profit (loss) for the period 9904 -€171 -€24,909 -€24,738 -14,506%
Profit (loss) for the period to be appropriated 9905 -€171 -€24,909 -€24,738 -14,506%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.